| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $168K | +6.45K | +0.97% | $26.10 | 673K | May 12, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$814K | -6.45K | -0.96% | $126.18 | 666K | May 12, 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $276K | +10.6K | +1.59% | $26.10 | 677K | May 12, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.33M | -10.6K | -1.57% | $125.39 | 666K | May 12, 2022 | Direct | F1, F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -6.45K | -9.46% | $0.00 | 61.7K | May 12, 2022 | Common Stock | 6.45K | $26.10 | Direct | F5 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -10.6K | -17.16% | $0.00 | 51.1K | May 12, 2022 | Common Stock | 10.6K | $26.10 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $126.00 to $126.55. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $125.00 to $125.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |